carbamates has been researched along with tg101209 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amaru Calzada, A; Donadoni, L; Finazzi, G; Gatta, R; Golay, J; Introna, M; Lombardi, L; Mantovani, R; Neri, A; Pellicioli, A; Rambaldi, A; Todoerti, K; Tuana, G | 1 |
1 other study(ies) available for carbamates and tg101209
Article | Year |
---|---|
The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.
Topics: Carbamates; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; NF-E2 Transcription Factor, p45 Subunit; Phosphorylation; Proto-Oncogene Proteins c-myb; Pyrimidines; Signal Transduction; Sulfonamides | 2012 |